US Stock MarketDetailed Quotes
CTSO Cytosorbents
- 1.010
- +0.119+13.36%
Close Dec 13 16:00 ET
- 1.010
- 0.000-0.01%
Post 20:01 ET
55.38MMarket Cap-2.81P/E (TTM)
1.090High0.890Low405.56KVolume0.900Open0.891Pre Close397.19KTurnover0.87%Turnover RatioLossP/E (Static)54.83MShares2.15052wk High4.26P/B47.00MFloat Cap0.70052wk Low--Dividend TTM46.53MShs Float98.750Historical High--Div YieldTTM22.42%Amplitude0.700Historical Low0.979Avg Price1Lot Size
About Cytosorbents Company
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Company Profile
SymbolCTSO
Company NameCytosorbents
Listing DateDec 23, 2014
Founded1997
CEODr. Phillip P. Chan, M.D.,PhD
MarketNASDAQ
Employees186
Fiscal Year Ends12-31
Address305 College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-732-329-8885
Websitehttp://cytosorbents.com
Company Executives
- Name
- Position
- Salary
- Dr. Phillip P. Chan, M.D.,PhD
- Chief Executive Officer and Director
- 1.33M
- Peter J. Mariani
- Chief Financial Officer
- --
- Vincent J. Capponi, M.S.
- President and Chief Operating Officer
- 1.11M
- Dr. Efthymios Nikolaos Deliargyris, M.D.
- Chief Medical Officer
- 1.06M
- Michael G. Bator
- Chairman of the Board
- 161.70K
- Jiny Kim, M.B.A.
- Independent Director
- 101.80K
- Alan D. Sobel, C.P.A.
- Independent Director
- 118.47K
- Dr. Edward R. Jones, M.B.A.,M.D.
- Independent Director
- 101.93K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
